Episode: Two Days of Reckoning for Opioid Makers


The Journal. Logo
Subscribe
Two Days of Reckoning for Opioid Makers
On Monday, a judge ordered Johnson and Johnson to pay Oklahoma $572 million for its role in the state's opioid crisis. And Tuesday, news broke that Purdue Pharma, the manufacturer of OxyContin, is in talks to resolve more than 2,000 opioid cases in a deal worth as much as $12 billion. WSJ's Sara Randazzo explains what the past two days mean for the fight to hold drugmakers legally accountable.

The Journal.
Users who viewed this episode also viewed...

The Journal. > The Dangerous Products on Amazon

A WSJ investigation has found that thousands of items offered by third-party sellers on Amazon have been declared unsafe, are deceptively labeled, or have been banned by federal regulators. Alexandra Berzon and Justin Scheck share the findings of their reporting.

The Journal. > Money's Role in College Admissions

Emails disclosed this week at the University of Southern California show how the school weighed donations in considering whether to admit students. Plus, the story of the SAT's "adversity score."

The Journal. > Uber and Lyft's Zero-Sum Game

Some investors say that for Uber to truly succeed, it needs to eliminate its competition. After two disappointing listings, can Uber and Lyft co-exist? Maureen Farrell has been covering Uber and Lyft's IPOs. Plus, a boss gets a major shock when he tries to help a sick employee. Update: Lyft raised more than $2 billion in its IPO...
Comments (0)

Login or Sign up to leave a comment.

Log in
Sign up

Be the first to comment.